Predictive and personalised medicine for asthma using genomics

S. Weiss (Boston, United States of America)

Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
Disease area: Airway diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Weiss (Boston, United States of America). Predictive and personalised medicine for asthma using genomics. Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biomarkers and personalised medicine for asthma
Source: Eur Respir J, 53 (1) 1802094; 10.1183/13993003.02094-2018
Year: 2019



The future of personalised medicine in COPD
Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease
Year: 2016


Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging
Source: Virtual Congress 2021 – Precision medicine in asthma and COPD
Year: 2021


In the era of personalized medicine, what are the current unmet needs in asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019

Asthma susceptibility: from pathophysiology to personalised medicine
Source: International Congress 2015 – ME4 Asthma susceptibility
Year: 2015




A personalised medicine approach to ICS use in COPD
Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care
Year: 2019

Personalised medicine in asthma: from curative to preventive medicine
Source: Eur Respir Rev 2017; 26: 160010
Year: 2017



Proteomic research tools for respiratory medicine
Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow
Year: 2008



Evaluation of the use of e-learning in training management of asthma and COPD in general medicine.
Source: International Congress 2017 – Medical education, web and internet
Year: 2017

Computational challenges of personalised medicine: from bench to bedside
Source: Virtual Congress 2021 – Digital transformation in practice: enabling next-generation medicine
Year: 2021


Personalised medicine through biological subphenotyping of ARDS
Source: Virtual Congress 2021 – Acute respiratory distress syndrome phenotypes: implications for diagnosis and treatment
Year: 2021

Spatial transcriptomics for respiratory research and medicine
Source: Eur Respir J, 58 (1) 2004314; 10.1183/13993003.04314-2020
Year: 2021



Personalised medicine in paediatric asthma, including from the patient's perspective
Source: International Congress 2016 – PG8 Paediatric asthma
Year: 2016


Personalised medicine in exacerbations of COPD: the beginnings
Source: Eur Respir J 2012; 40: 1318-1319
Year: 2012


The basic science behind asthma biologics
Source: International Congress 2018 – New biologics for asthma: which patients, which agents, which results, at what cost?
Year: 2018


What is evidence-based medicine?
Source: Annual Congress 2006 - PG16 - The use of evidence-based medicine and practice for the clinician (jointly organised with the ACCP)
Year: 2006